Published

The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Risk management and healthcare policy
Date: 2021-01-01
Source: PubMed
DOI: 10.2147/rmhp.s300656
PubMed: 33707976

Authors

Dos Santos RG Bouso JC Rocha JM Rossi GN Hallak JE

Watch author

Derived topics and classifications

psilocybin Mechanism of Action Receptor Pharmacology Clinical Trial Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Could psilocin rescue chronic, stress-accelerated, transcriptional aging in brain?UKnowledge (University of Kentucky) · 2025-03-04 Psychedelics and mental health: reimagining care through science, insight, and compassion.Frontiers in pharmacology · 2025-01-01 Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelicsFrontiers in Psychiatry · 2024-11-06 Mindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) for cancer-related demoralization in Canada: The case for a hybrid group-based delivery modelPsychedelics · 2026-12-01 Psilocybin exerts differential effects on social behavior and inflammation in mice in contexts of activity-based anorexiaPsychedelics. · 2026-02-03 Psychedelics in the context of stress and psychiatric disorders: A new horizon in mental health treatmentPsychedelics. · 2025-10-14 Michael A. Wheeler: Psychedelics and neuroimmune circuits-what a strange trip, indeedPsychedelics. · 2025-05-06 Psychedelic treatment for anorexia nervosa: A first-hand view of how psilocybin treatment did and did not helpPsychedelics. · 2024-11-07